Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD24


Brief Information

Name:Signal transducer CD24
Target Synonym:Small cell lung carcinoma cluster 4 antigen,CD24A,CD24 Antigen (Small Cell Lung Carcinoma Cluster 4 Antigen),CD24 Molecule,CD24 Antigen
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data


Immobilized Human CD24 Protein, His Tag (Cat. No. CD4-H52H5) at 5 μg/mL (100 μL/well) can bind Anti-CD24 MAb (SN3) with a linear range of 5-78 ng/mL (QC tested).


Immobilized Human CD24, His Tag-Ferritin (Cat. No. CD4-H5246) at 5 μg/mL (100 μL/well) can bind Anti-CD24 MAb (SN3) with a linear range of 10-625 ng/mL (QC tested).

Synonym Name



CD24 may have a pivotal role in cell differentiation of different cell types. Signaling could be triggered by the binding of a lectin-like ligand to the CD24 carbohydrates, and transduced by the release of second messengers derived from the GPI-anchor. Modulates B-cell activation responses. Promotes AG-dependent proliferation of B-cells, and prevents their terminal differentiation into antibody-forming cells. In association with SIGLEC10 may be involved in the selective suppression of the immune response to danger-associated molecular patterns (DAMPs) such as HMGB1, HSP70 and HSP90. Plays a role in the control of autoimmunity.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
IBD-0333 IBD-0333; IBD0333 Phase 2 Clinical SunHo (China) BioPharmaceutical Co Ltd Solid tumours; Neoplasms; Lymphoma, Non-Hodgkin Details
ATG-031 ATG-031; ATN-031 Phase 1 Clinical Antengene Corporation Co Ltd Lymphoma, B-Cell; Solid tumours; Hematologic Neoplasms Details
NXA-01 NXA01; NXA-01 Phase 1 Clinical Beijing Xingkangyuan Biotechnology Co Ltd Solid tumours Details
KH-801 KH-801; KH801 Phase 1 Clinical Chengdu Kanghong Pharmaceutical Group Co Ltd Solid tumours; Neoplasms Details
ONC-841 ONC-841 Phase 1 Clinical Oncoimmune-Guangzhou Solid tumours; Neoplasms Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message